Literature DB >> 23616064

Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics.

Cristina Gervasoni, Dario Cattaneo, Felicia Stefania Falvella, Paola Vitiello, Stefania Cheli, Laura Milazzo, Emilio Clementi, Agostino Riva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23616064     DOI： 10.1007/s00228-013-1515-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  16 in total

Review 1.  Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications.

Authors:  Aki Sakurai; Ai Tamura; Yuko Onishi; Toshihisa Ishikawa
Journal:  Expert Opin Pharmacother       Date:  2005-11       Impact factor: 3.889

2.  Post-marketing surveillance of the safety of levofloxacin in Japan.

Authors:  Hiroki Yamaguchi; Hitomi Kawai; Takuyuki Matsumoto; Hiroo Yokoyama; Toshio Nakayasu; Masahiro Komiya; Jingoro Shimada
Journal:  Chemotherapy       Date:  2007-01-26       Impact factor: 2.544

3.  Identification of influx transporter for the quinolone antibacterial agent levofloxacin.

Authors:  Tomoji Maeda; Koichi Takahashi; Naoko Ohtsu; Toshihiro Oguma; Toshimasa Ohnishi; Ryo Atsumi; Ikumi Tamai
Journal:  Mol Pharm       Date:  2007 Jan-Feb       Impact factor: 4.939

Review 4.  Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.

Authors:  April D Miller; Amanda M Ball; P Brandon Bookstaver; Emily K Dornblaser; Charles L Bennett
Journal:  Pharmacotherapy       Date:  2011-04       Impact factor: 4.705

Review 5.  Seizures associated with fluoroquinolones.

Authors:  J M Kushner; H J Peckman; C R Snyder
Journal:  Ann Pharmacother       Date:  2001-10       Impact factor: 3.154

Review 6.  Antimicrobial safety: focus on fluoroquinolones.

Authors:  Robert C Owens; Paul G Ambrose
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079

Review 7.  Pharmacogenetics of the organic anion transporting polypeptide 1A2.

Authors:  Ryan M Franke; Lisa A Scherkenbach; Alex Sparreboom
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

8.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Authors:  Deanna L Kroetz; Christiane Pauli-Magnus; Laura M Hodges; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Doug Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Elaine J Carlson; Ira Herskowitz; Kathleen M Giacomini; Andrew G Clark
Journal:  Pharmacogenetics       Date:  2003-08

Review 9.  Safety concerns with fluoroquinolones.

Authors:  Allana J Mehlhorn; Dana A Brown
Journal:  Ann Pharmacother       Date:  2007-10-02       Impact factor: 3.154

10.  Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood-brain barrier: a case study examining sorafenib efflux clearance.

Authors:  Sagar Agarwal; William F Elmquist
Journal:  Mol Pharm       Date:  2012-02-22       Impact factor: 4.939
View more
  2 in total

1.  Association between oral fluoroquinolones and seizures: A self-controlled case series study.

Authors:  Celine S L Chui; Esther W Chan; Angel Y S Wong; Adrian Root; Ian J Douglas; Ian C K Wong
Journal:  Neurology       Date:  2016-04-06       Impact factor: 9.910

Review 2.  Pharmacogenomics of Antibiotics.

Authors:  Gabriele Stocco; Marianna Lucafò; Giuliana Decorti
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.